What is the innovation?
The project aims to generate new evidence on the dynamics of community engagement and establish a global community of evidence and practice around community engagement for vaccination in humanitarian settings. It explores existing practices and challenges involved in vaccine uptake and delivery, developing guidance and tools for community-led vaccine deployment strategies.
Why we need to innovate
Despite consensus on the importance of community engagement in effective vaccination programmes, we do not know which strategies are most effective at improving vaccination uptake – vaccination programmes are not fully co-developed with local communities, and evaluation evidence is lacking on how the co-production process affects vaccine deployment strategies.
What is the opportunity?
Vaccine delivery challenges are complex and interconnected, ranging from logistical concerns to health system capacity and confidence in vaccines. Rather than treating communities as passive recipients, the project will co-design vaccine delivery programmes with them, collaboratively developing and evaluating community engagement strategies to help overcome implementation challenges.
Investment summary
- Investment type
- Accelerated innovation collaborations
- People involved
Dr Sharon Abramovitz, Rachel Bassidy, Rose Burns, Karl Blanchet, Emily Eldred, Luisa Enria, Shelley Lees, Jonathan Polonski, Dr Ana Santos
- Project length
- 18 months
- Locations
UK, Switzerland, Nigeria and Ethiopia
- Collaborations
-
-
